SCHEMBL4953282

SCHEMBL4953282

O=C(COc1c(F)cccc1Cl)N1CCC2(CC1)C(=O)Nc1ccccc12

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 11/20 0.46
HTR2A P28223 11/20 0.46
HTR7 P34969 11/20 0.46
HTR6 P50406 11/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TSHR P16473 1/20 0.44
OPRM1 P35372 1/20 0.41
OPRK1 P41145 1/20 0.41
OPRL1 P41146 1/20 0.41
HTT P42858 1/20 0.40
POLB P06746 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
GHSR Q92847 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4952253 0.93 OPRM1 (0.45) HTR1AHTR2AHTR7HTR6MEN1
SCHEMBL4953313 0.93 HTR1A (0.49) HTR1AHTR2AHTR7HTR6MEN1
SCHEMBL4953406 0.85 HTR1A (0.46) HTR1AHTR2AHTR7HTR6MEN1
SCHEMBL4952842 0.85 FKBP1A (0.56) HTR1AHTR2AHTR7HTR6MEN1
SCHEMBL4952515 0.85 MEN1 (0.59) HTR1AHTR2AHTR7HTR6MEN1
SCHEMBL4948817 0.84 MEN1 (0.50) HTR1AHTR2AHTR7HTR6MEN1
SCHEMBL4955471 0.84 FKBP1A (0.47) HTR1AHTR2AHTR7HTR6MEN1
SCHEMBL4954092 0.83 ATF4 (0.56) HTR1AHTR2AHTR7HTR6TDP1
SCHEMBL4948705 0.83 OPRM1 (0.45) HTR1AHTR2AHTR7HTR6MEN1
SCHEMBL4951614 0.82 OPRM1 (0.44) HTR1AHTR2AHTR7HTR6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME HSD11B1, HSD11B2, HSD3B1 HTR1A 815/4885HTR2A 1155/4885HTR7 774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.